title: Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.
abstract: Parkinson's disease (PD) is a neurodegenerative condition characterized by chronic inflammation. Nuclear factor κB (NF-κB) is a family of inducible transcription factors that are expressed in a wide variety of cells and tissues, including microglia, astrocytes, and neurons, and the classical NF-κB pathway plays a key role in the activation and regulation of inflammatory mediator production during inflammation. Activation of the classical NF-κB pathway is mediated through the activity of the IKK kinase complex, which consists of a heterotrimer of IKKα, IKKβ, and IKKγ subunits. Targeting NF-κB has been proposed as an approach to the treatment of acute and chronic inflammatory conditions, and the use of inhibitors specific for either IKKβ or IKKγ has now been found to inhibit neurodegeneration of TH+ DA-producing neurons in murine and primate models of Parkinson's disease. These studies suggest that targeting the classical pathway of NF-κB through the inhibition of the IKK complex can serve as a useful therapeutic approach to the treatment of PD.
authors: Department of Periodontology and the Comprehensive Center for Inflammatory Disorders, University of North Carolina, Chapel Hill, NC 27599-7454, USA.
authors: Patrick M
authors: PM
authors: Flood
authors: Li
authors: L
authors: Qian
authors: Lynda J
authors: LJ
authors: Peterson
authors: Feng
authors: F
authors: Zhang
authors: Jing-Shan
authors: JS
authors: Shi
authors: Hui-Ming
authors: HM
authors: Gao
authors: Jau-Shyong
authors: JS
authors: Hong
references: Neurosci Lett. 1994 Jan 3;165(1-2):208-10
references: 8015728
references: Sci STKE. 2005 Feb 22;2005(272):pe7
references: 15728425
references: J Clin Invest. 2010 Jul;120(7):2563-74
references: 20530876
references: Neuroscience. 1996 May;72(2):355-63
references: 8737406
references: J Neuroinflammation. 2008 Oct 17;5:45
references: 18925972
references: Crit Rev Neurobiol. 2004;16(4):271-302
references: 15862109
references: Exp Neurol. 2009 Dec;220(2):230-3
references: 19815009
references: J Pharmacol Exp Ther. 2010 Jun;333(3):822-33
references: 20190013
references: BMC Neurosci. 2010 Apr 30;11:57
references: 20433710
references: J Neurosci. 2002 May 15;22(10):3898-909
references: 12019309
references: J Biol Chem. 2002 Nov 29;277(48):45992-6000
references: 12244103
references: Mov Disord. 1998;13 Suppl 1:24-34
references: 9613715
references: J Leukoc Biol. 1999 Mar;65(3):291-8
references: 10080530
references: Transpl Infect Dis. 2001 Dec;3(4):212-9
references: 11844153
references: Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a000158
references: 20300203
references: Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2458-66
references: 20930169
references: Proc Natl Acad Sci U S A. 2004 May 25;101(21):7994-8
references: 15148408
references: J Neural Transm (Vienna). 2010 Aug;117(8):971-9
references: 20571837
references: J Biol Chem. 2004 Dec 3;279(49):51647-53
references: 15383538
references: J Biol Chem. 2010 Feb 19;285(8):5479-87
references: 20018862
references: Mol Cell. 2002 Oct;10(4):693-5
references: 12419209
references: J Immunol. 2011 Apr 1;186(7):4443-54
references: 21335487
references: Curr Pharm Des. 2007;13(18):1925-8
references: 17584117
references: Clin Neuropharmacol. 1994 Aug;17(4):370-9
references: 9316685
references: Neurol Res. 2005 Oct;27(7):717-25
references: 16197808
references: J Leukoc Biol. 2007 Sep;82(3):729-41
references: 17537988
references: J Immunol. 2007 Dec 1;179(11):7852-9
references: 18025231
references: J Biol Chem. 2004 Sep 3;279(36):37219-22
references: 15252035
references: Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S9-S15
references: 15885630
references: Annu Rev Immunol. 2009;27:119-45
references: 19302036
references: Agents Actions Suppl. 1995;47:135-41
references: 7540353
references: Immunol Res. 2008;41(3):155-64
references: 18512160
references: Br J Pharmacol. 2005 May;145(2):178-92
references: 15753951
references: J Neurochem. 2008 Mar;104(6):1504-25
references: 18036154
references: Arthritis Rheum. 2005 Mar;52(3):951-8
references: 15751079
references: J Alzheimers Dis. 2007 Jun;11(3):305-11
references: 17851181
references: Mol Cell Biol. 2002 Dec;22(23):8175-83
references: 12417721
references: Cold Spring Harb Perspect Biol. 2009 Sep;1(3):a000075
references: 20066103
references: Nat Cell Biol. 2007 Apr;9(4):461-9
references: 17351639
references: Mov Disord. 2007 Oct 15;22(13):1852-6
references: 17592621
references: J Neurosci Res. 2008 Feb 1;86(2):317-25
references: 17787016
references: Nature. 2004 Apr 8;428(6983):660-4
references: 15071597
references: Oncogene. 2003 Nov 27;22(54):8797-801
references: 14647474
references: Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18754-9
references: 18000063
references: Prog Neurobiol. 2005 Jun;76(2):77-98
references: 16081203
references: J Natl Cancer Inst. 2008 Jun 18;100(12):862-75
references: 18544741
references: Eur J Neurosci. 2002 Mar;15(6):991-8
references: 11918659
references: J Pharm Pharmacol. 2004 Feb;56(2):145-60
references: 15005873
references: Int J Biochem Cell Biol. 2010 Apr;42(4):519-23
references: 20026420
references: Science. 2000 Sep 1;289(5484):1550-4
references: 10968790
references: Am J Transplant. 2009 Mar;9(3):452-62
references: 19260829
references: J Intern Med. 2008 Jun;263(6):591-6
references: 18479258
references: J Neurosci. 2008 Oct 22;28(43):10825-34
references: 18945890
references: Int J Biochem Cell Biol. 2008;40(8):1425-30
references: 17693123
references: Clin Sci (Lond). 2010 Feb 23;118(10):593-605
references: 20175746
references: FASEB J. 2007 Sep;21(11):2642-54
references: 17431096
references: Ann Neurol. 2003 Nov;54(5):599-604
references: 14595649
references: Cell. 1986 Dec 26;47(6):921-8
references: 3096580
references: Acta Neuropathol. 2003 Dec;106(6):518-26
references: 14513261
references: Am J Pathol. 1997 Aug;151(2):375-87
references: 9250151
references: Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2248-53
references: 17675566
references: Physiol Rev. 2010 Apr;90(2):495-511
references: 20393192
references: Annu Rev Immunol. 2001;19:683-765
references: 11244051
references: Neurology. 1988 Aug;38(8):1285-91
references: 3399080
references: Parkinsonism Relat Disord. 2005 Nov;11(7):435-9
references: 16154791
references: J Invest Surg. 2009 Jul-Aug;22(4):301-15
references: 19842907
references: Nature. 2003 Jun 5;423(6940):655-9
references: 12789342
references: Neurosci Lett. 2007 Feb 27;414(1):94-7
references: 17196747
references: Neurosci Lett. 1994 Oct 24;180(2):147-50
references: 7700568
references: Neurochem Int. 2010 Dec;57(8):876-83
references: 20868715
references: Genes Dev. 2000 Apr 1;14(7):854-62
references: 10766741
references: Nature. 2003 Jun 5;423(6940):659-63
references: 12789343
references: Crit Rev Immunol. 2001;21(5):427-49
references: 11942558
references: J Interferon Cytokine Res. 1999 May;19(5):429-38
references: 10386854
references: Oncogene. 2006 Jan 19;25(3):387-98
references: 16170348
references: J Biol Chem. 2002 May 10;277(19):16639-47
references: 11872748
references: Adv Neuroimmunol. 1996;6(2):191-22
references: 8876774
references: Trends Immunol. 2008 Aug;29(8):357-65
references: 18599350
references: J Neural Transm Suppl. 2000;(60):277-90
references: 11205147
references: Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S200-4
references: 20082990
references: Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7531-6
references: 9207126
references: Neuroreport. 1995 Aug 21;6(12):1642-4
references: 8527732
references: Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034
references: 20066092
references: Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651
references: 20457564
references: Neurochem Int. 2001 Nov-Dec;39(5-6):333-40
references: 11578768
references: Development. 2001 May;128(9):1559-72
references: 11290295
references: Mol Neurobiol. 2003 Dec;28(3):209-18
references: 14709785
references: Neuron. 2003 Sep 11;39(6):889-909
references: 12971891
references: J Cell Biol. 2008 Feb 25;180(4):787-802
references: 18299349
references: Neuron. 1988 Oct;1(8):623-34
references: 2908446
references: Mol Neurobiol. 2010 Jun;41(2-3):242-7
references: 20195798
references: Nat Med. 2004 Jun;10(6):617-24
references: 15156202
references: Cell. 1986 Aug 29;46(5):705-16
references: 3091258
references: J Pharmacol Exp Ther. 2005 Jan;312(1):373-81
references: 15316093
references: Arthritis Res Ther. 2008;10(4):212
references: 18771589
references: Neurochem Res. 2008 Oct;33(10):2044-53
references: 18368483
references: J Clin Invest. 2001 Jan;107(1):7-11
references: 11134171
references: J Biol Chem. 2002 Feb 8;277(6):3863-9
references: 11733537
references: Brain Res Bull. 2008 Jul 30;76(5):505-11
references: 18534259
references: Immunol Rev. 2010 Jan;233(1):55-61
references: 20192992
references: Parkinsonism Relat Disord. 2007;13 Suppl 3:S316-20
references: 18267257
references: J Bone Miner Res. 2010 Apr;25(4):809-18
references: 19839765
references: J Invest Dermatol. 2010 Apr;130(4):1073-86
references: 19940859
references: J Neuroimmunol. 2005 Jul;164(1-2):105-14
references: 15899524